Sale20 Nov 2024, 07:54 pm
Natco Pharma Sells Investment in ISCA, Inc., Generating USD 2.06 Million
AI Summary
Natco Pharma Ltd. has sold its investment in ISCA, Inc., a Delaware Corporation. The sale generated total consideration of USD 2,061,102.10 (equivalent to INR 173,895,184.18). The buyer, DE SANGOSSE SAS, is organized under the laws of France and does not belong to the promoter/promoter group/group companies. This transaction is not a related party transaction and does not fall within the Scheme of Arrangement.
Key Highlights
- Natco Pharma sold its investment in ISCA, Inc., generating USD 2.06 Million
- The buyer, DE SANGOSSE SAS, is based in France and is not related to the promoter/promoter group/group companies
- This transaction is not a related party transaction
- The sale does not fall within the Scheme of Arrangement
- The sale consideration is equivalent to INR 173,895,184.18